NASDAQ : DAVI

Davion Healthcare Plc — Company profile

Healthcare · Medical Devices · Ireland

Last price 1.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.00M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.

Details

NameDavion Healthcare Plc
SectorHealthcare
IndustryMedical Instruments & Supplies
Founded2022
CeoGlenn Williams
CountryIreland
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyEUR
Ipo Price12.00
IsinIE000GVCI8S8
Cik2039072
Sic3841

Key executives

NameTitle
Glenn WilliamsChief Executive Officer
Andreas TtofiChief Financial Officer
Jeremy NorthChief Operating Officer

Contact

AddressWest Cork Business & Technology Park, Unit A, Cork, P85 FV48, Ireland
Phone353 238 808 958
Websitehttps://www.davionhealthcare.com